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Background. Mobile teledermatology has recently been shown to be suitable for teledermatology despite limitations in image
definition in preliminary studies. The unique aspect of mobile teledermatology is that this system represents a filtering or
triage system, allowing a sensitive approach for the management of patients with emergent skin diseases. Methodology/
Principal Findings. In this study we investigated the feasibility of teleconsultation using a new generation of cellular phones
in pigmented skin lesions. 18 patients were selected consecutively in the Pigmented Skin Lesions Clinic of the Department of
Dermatology, Medical University of Graz, Graz (Austria). Clinical and dermoscopic images were acquired using a Sony Ericsson
with a built-in two-megapixel camera. Two teleconsultants reviewed the images on a specific web application (http://www.
dermahandy.net/default.asp) where images had been uploaded in JPEG format. Compared to the face-to-face diagnoses, the
two teleconsultants obtained a score of correct telediagnoses of 89% and of 91.5% reporting the clinical and dermoscopic
images, respectively. Conclusions/Significance. The present work is the first study performing mobile teledermoscopy using
cellular phones. Mobile teledermatology has the potential to become an easy applicable tool for everyone and a new approach
for enhanced self-monitoring for skin cancer screening in the spirit of the eHealth program of the European Commission
Information for Society and Media.
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INTRODUCTION
The development of user-friendly technology has brought personal
digital assistants (PDA) and cellular phones into everyday use. The
power of these devices allows their use in more demanding tasks
such as processing medical images; their use in telemedicine and
particular in teledermatology has been recently proven and the
name ‘‘mobile teledermatology’’ has been coined.[1,2] In the first
pilot studies limitations in image definition of cellular phones have
been found, because the optics of the first generation cellular
phones did not allow close-up or macro imaging.[1–3] Neverthe-
less, these studies have shown the usability and the feasibility of
these new devices in teledermatology.[1–3] In fact, the unique
aspect of mobile teledermatology is that this system might become
a filtering or triage system allowing a more sensible approach for
the management of patients with emergent skin diseases.[1–5] In
addition, mobile teledermatology may also become a powerful
screening tool for malignant cutaneous tumors. Skin cancers
constitute nowadays the most common malignancies in the
Caucasian population and the incidence has reached epidemic
proportions.[6] Non-melanoma skin cancer (basal cell carcinoma,
BCC, and squamous cell carcinoma, SCC) have an estimated
incidence of over 600.000 cases per year in the U.S. (with a ratio of
BCC to SCC of 4:1), 20 times greater than that of melanoma.[7]
In the past 25 years melanoma incidence has increased most
rapidly than any other cancer, being now 18 new cases per
100.000 population per year in U.S.[8] Melanoma survival is
related to its stage depending directly on melanoma thickness. A
non ulcerated melanoma thinner than 1 mm has a 5-year survival
of 95%, while an ulcerated melanoma thicker than 4 mm and with
node metastases has a 5-year survival of only 24%.[9] For this
reason early detection of thin melanoma is crucial, as the surgical
excision today is the only life-saving approach.[10,11] The
accuracy of traditional clinical diagnosis of melanoma ranges
between 65–80%.[12] Moreover, the naked-eye examination
based on the ABCD system may fail to detect the so called small
melanomas as well as melanoma regular in shape and/or
colour.[13] Dermoscopy (in the past also called epiluminescence
microscopy, dermatoscopy, surface microscopy), a recent, non-
invasive, in vivo technique, has the potential to improve up to 49%
the diagnostic accuracy for melanoma if used by experts.[14,15] In
this study we investigated the feasibility to perform melanoma
screening with both clinical and dermoscopic images acquired
using a new generation of cellular phones.
MATERIALS AND METHODS
Eighteen consecutive patients (M:F=12:6; mean age: 43,38;
median age: 45; range: 14–78) were selected in the Pigmented
Skin Lesions Clinic of the Department of Dermatology, Medical
University of Graz, Graz (Austria) during two routine working
days. Only patients who agreed to the study and signed the patient
consent were enrolled. The face-to-face (FTF) diagnoses (16
benign lesions and 2 melanomas, Table 1) were made in each case
by the same board-certified dermatologist (RHW). Images have
been acquired under routine conditions and without additional
light sources using a Sony Ericcson K 750i with a built-in
2 megapixel camera with autofocus, macro mode and zoom. In
each case a close up clinical image and a dermoscopic image
applying the cellular phone on a pocket dermoscopy device with
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Point, USA); Figure 1) has been taken. Images had
163261224 pixels resolution with macro mode and were stored
in JPEG format with an average size of 357 kilobytes (range 256–
471 kilobytes). Images were transferred and saved on a computer
using an USB port. Subsequently 2 images of each case (a clinical
and a dermoscopic image) without clinical data were sent to 2
teleconsultants (HPS, CM) via a virtual private network (www.
dermahandy.net/default.asp, e-derm-consult GmbH - Graz,
Austria) based on store-and-forward systems (SAF; Figure 2).[16]
The 2 teleconsultants reviewed the cases independently from each
other and answered directly on the web application. A LAN
connection was available for both teleconsultants. One of them
used a Sony VAIO with a 15.40 LCD screen; the other a Fujitsu
Siemens Computer with a 15.40 LCD screen. Both teleconsultants
reviewed firstly the clinical images, made their clinical diagnosis
and afterwards reviewed the dermoscopic images of each case and
provided the dermoscopic diagnosis. Teleconsultants were asked to
give the specific diagnosis for each case (i.e. ‘‘dysplastic nevus’’,
‘‘blue nevus’’) and only one diagnosis was accepted. The
telediagnoses were compared with the FTF diagnosis which was
taken as correct. Generic diagnoses as ‘‘nevus’’ have not been
accepted and if more than one telediagnosis had been given, only
the first one was considered as correct. We defined as diagnostic
agreement the concordance between the telediagnosis and the
FTF diagnosis. Excisions of the lesions with consequent histo-
pathologic diagnosis were performed in 3 cases (2, 9 and 18).
Teleconsultants were also asked to judge the quality of each image
with the following scale: poor, fair, good, excellent (Table 1).
RESULTS
Regarding the clinical images, the 2 teleconsultants agreed both
with the FTF diagnosis in 89% (16/18); two dysplastic nevi (case 6
and 11) have been overdiagnosed as melanomas, a dermatofi-
broma (case 16) was diagnosed as dysplastic nevus and a melanoma
(case 18) was underdiagnosed as seborrheic keratosis (Table 1).
Reporting the dermoscopic images, the diagnostic agreement was
89% (16/18) in teleconsultant A and 94% (17/18) in teleconsul-
tant B, respectively. A dysplastic nevus (case 6; both teleconsul-
tants) and a congenital nevus (case 14; teleconsultant A) were
overdiagnosed as melanomas (see also Table 1). The interobserver
agreement among our 2 teleconsultants was of 89% and 94% for
the clinical and dermoscopic telediagnoses, respectively. Quality of
clinical images has been judged poor for 11 cases (31%), fair for 14
cases (39%), good for 7 cases (19%) and excellent for 4 cases (11%).
Concerning the dermoscopic images, 4 cases (11%) have been
judged poor, 15 cases (42%) fair, 15 cases (42%) good and 2 cases
(5%) revealed excellent image quality.
DISCUSSION
Teledermoscopy represents a recent development of teledermatol-
ogy. Dermoscopic images of pigmented skin lesions can be
transmitted through internet to remote teleconsultants. The
feasibility of teledermoscopy has been already proven by previous
studies. In 1998, Provost et al. showed a high concordance in the
diagnosis of atypical (dysplastic) melanocytic nevi and early
melanoma between four different clinicians when comparing
conventional slides with transmitted, compressed, digitized
images.[17] One year later, in 1999, Piccolo et al. found
a diagnostic concordance of 91% among FTF diagnosis and
telediagnosis of 66 pigmented skin lesions sent via-email to
a remote teleconsultant.[18] In 2000, in a subsequent multicentre
study the same authors reported an average of correct tele-
diagnoses of 85% in a subset of 43 cutaneous pigmented skin
lesions sent by e-mail to 11 colleagues with different degrees of
experience in dermoscopy.[19] In the same year, Braun et al.
reported a teledermoscopic study in which six private dermatol-
ogists sent clinical and dermoscopic images of 55 pigmented skin
lesions to the Department of Dermatology at the University of
Geneva for teleconsultation over a period of 6 months. Their
results showed that the diagnostic accuracy of teledermoscopy was
superior to the one obtained on a FTF basis.[20] Recently,
Moreno-Ramirez and colleagues evaluated teledermoscopy as
a filtering system on 219 pigmented skin lesions. Teleconsultations
were sent from general practitioner (GP) to the pigmented skin
lesion clinic of the Department of Dermatology, University of
Seville, in Seville/Spain. The outcome of the teleconsultation was
that 49% of the patients were referred to the FTF clinic. The
Figure 1. This dermoscopic image of a pigmented skin lesion has
been captured applying the cellular phone on a pocket epilumines-
cence microscopy device.
doi:10.1371/journal.pone.0000483.g001
Figure 2. Clinical (A) and dermoscopic images (B) of a melanoma (case
9).
doi:10.1371/journal.pone.0000483.g002
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both the diagnosis (k=0,91) and for the management options
(k=0,92).[21] In particular, teledermoscopy seems to be suitable
mostly as a triage system. In fact, Carli et al. stated that the
examination of lesions (including dermoscopy) without contact
with the patient is associated with improper management in about
30% of equivocal melanomas.[22]
The present work is the first study performing mobile
teledermoscopy using cellular phones with an in-built camera.
Moreover, this is the first time that a simply hand-held dermoscopy
device has been used for a teledermoscopy study. In fact, we
captured the dermoscopic images applying directly the cellular
phone on a pocket dermoscope while in all the previously reported
teledermoscopic studies the images had been acquired with an
integrated digital dermoscopy device.[15] Again, in contrast with
previous studies that transmitted the images via e-mail, we have
tested a specific web application suited for teledermoscopy (www.
dermahandy.net/default.asp). Comparing our results with those of
previous studies in mobile teledermatology using cellular phones
and PDA, it is not surprising that results are better when using the
new generation of cellular phones.[1–3] In fact, the resolution of the
in-built cameras in the new generation of cellular phones resolved
the issue of the image quality found in the previous reports. This
problem was due to limitations of the optics of the first generation
cellular phones that were not designed for close-up macroimaging
thus resulting in out of focus close-up images.[1–3] Still the images
captured with the new generation of cellular phones are far from
being perfect. In fact, 31% and 11% of clinical and dermoscopic
images, respectively, have been judged by our teleconsultants as of
poor quality as images revealed low sharpness and were not
perfectly in focus. However, it seems likely that the routine
conditions under which images have been captured were re-
sponsible for the low image quality rather than technical limitations.
Although image quality did not represent an impediment to
formulate the correct diagnosis in most instances, the reduced image
quality in cases 6 and 11 might have influenced the telediagnosis.
Further studies on larger series of cases are needed to study the
influence of image quality on mobile telediagnoses.
Considering our clinical telediagnoses, a melanoma (case 18) has
been underdiagnosed by one of our teleconsultants, 2 benign
melanocytic nevi (cases 6 and 11) have been overdiagnosed as
melanoma and a dermatofibroma (case 16) has been reported as
a dysplastic nevus. Interestingly, reporting the dermoscopic images
of case 11, 16 and 18 the teleconsultants changed their diagnoses
Table 1. FTF diagnosis and telediagnosis of teleconsultant A and B.
..................................................................................................................................................
Case # FTF diagnosis
Clinical telediagnosis Dermoscopic telediagnosis
Image quality of clinical
pictures
Image quality of
dermoscopic pictures
A BABABAB
1 b l u e n e v u s 1 111P o o r Fair Fair Good
2 dysplastic nevus
" 1 1 1 1 Fair Fair Fair Fair
3 dysplastic nevus 1 111P o o r Poor Fair Fair
4 recurrent nevus 1 1 1 1 Fair Fair Fair Fair
5 dysplastic nevus 1 1 1 1 Good Good Good Good
6 dysplastic nevus 0* 1 0* 0* Poor Poor Fair Fair
7 seborrheic keratosis 1 1 1 1 Fair Fair Fair Fair
8 angioma 1 1 1 1 Fair Poor Fair Fair
9 melanoma
" 1 1 1 1 Excellent Good Excellent Good
10 congenital nevus 1 1 1 1 Fair Fair Poor Poor
11 dysplastic nevus 0
{ 111P o o r Poor Poor Poor
12 dysplastic nevus 1 111P o o r Poor Fair Fair
13 seborrheic keratosis 1 1 1 1 Excellent Good Excellent Good
14 congenital nevus 1 1 0
{ 1 Excellent Excellent Good Good
15 acral nevus 1 1 1 1 Good Good Good Good
16 dermatofibroma 1 0
1 1 1 Good Fair Good Good
17 angioma 1 1 1 1 Fair Poor Good Good
18 melanoma
" 10
|| 1 1 Fair Fair Good Good
Diagnostic
agreement 16/18 16/18 16/18 17/18
% 89% 89% 89% 94%
FTF: face to face
A: teleconsultant A
B: teleconsultant B
1: agreement with FTF
0: disagreement with FTF
*clinical and dermoscopic telediagnosis: melanoma
{clinical telediagnosis: melanoma
{dermoscopic telediagnosis: melanoma
1clinical telediagnosis: dysplastic nevus
||clinical telediagnosis: seborrheic keratosis
"diagnosis confirmed histopathologically
doi:10.1371/journal.pone.0000483.t001
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PLoS ONE | www.plosone.org 3 May 2007 | Issue 5 | e483achieving the agreement with the FTF and the 2 melanomas within
the 18 pigmented skin lesions were correctly identified dermosco-
pically by both teleconsultants. These results may be explained by
the fact that the clinical image alone in some cases is not enough to
reach the correct diagnosis of a given melanocytic proliferation and
underlines the value of dermoscopy in the diagnosis of melano-
ma.[11,15] In case 6 the two teleconsultants agreed on the diagnosis
of melanoma while the FTF diagnosis had been dysplastic nevus. It
must been underlined that clinical data had not been provided to
our teleconsultants in order to test their genuine capacity to
formulate a telediagnoses. Case 6 was a dysplastic nevus from a 42-
year old woman with a dysplastic nevus syndrome with clinically
numerous atypical moles similar to the one that has been included
in the study. Thus the lesion in debate was interpreted by the FTF
dermatologist as not revealing the ugly duckling sign and just
monitored and not excised.[23] Without this most important
clinical information both teleconsultants overdiagnosed clinically
and one also dermoscopically this lesion as melanoma.
Currently, in many medical specialities research in telemedicine
is focusing on developing and testing new ways to utilize cellular
phones for home-based health data acquisition. Home monitoring
using information and communication technologies is particularly
suitable for managing chronic diseases and a number of clinical
trials have indicated the value of this concept to optimize therapy
in hypertension, diabetes, asthma as well as to reduce hospitaliza-
tion for patients with heart failures.[24] The feasibility study
presented herein shows for the first time the potentiality of mobile
teledermatology and mobile teledermoscopy as a triage system for
pigmented skin lesions. In accordance with the new formulated
concept of ‘‘person-centred health system’’ this approach could
open up new horizons for persons with numerous moles and
suspicious pigmented skin lesions.[25,26] In fact, one of the
cardinal points of the eHealth program of the European
Commission Information Society and Media is the prevention
and management of diseases through research on ‘‘Personal
Health Systems’’. The hallmark of this concept is to empower
citizens to adopt an active role in managing their own health status
and, in addition, facilitating early diagnosis of diseases’’.[26] In
this context mobile teledermatology and mobile teledermoscopy
has the potential to become an easy applicable tool for everyone
and may open the door for a new flexible triage system for
detection of skin cancer in general and melanoma in particular. A
person concerned about a changing mole or a new mole can
capture an image of a given lesion with a cellular phone and send
it via multimedia messaging service (MMS) to a specialized
telemedicine centre for triage. Certainly, the legal aspects
concerning teleconsultations have to be revaluated based on
a new definition of doctor-patient-relationship. Moreover, pro-
spective, randomized clinical studies are needed to test and
standardize the proposed mobile triage system for pigmented skin
lesions. In conclusion, we foresee that in the near future there will
be an icon on the screen of cellular phones allowing to seek
directly for a telemedical consultation including advice for
dermatological conditions and allowing a virtual triage for new
and suspicious moles. So, mobile teledermatology and mobile
teledermoscopy is paving the way for early melanoma recognition
by enhanced self examination in the spirit of the eHealth program
of the European Commission for Information Society and Media.
ACKNOWLEDGMENTS
Author Contributions
Conceived and designed the experiments: HS CM RH. Performed the
experiments: HS CM RH VA CE. Analyzed the data: HS CM.
Contributed reagents/materials/analysis tools: CM GG. Wrote the paper:
CM.
REFERENCES
1. Massone C, Lozzi GP, Wurm E, Hofmann-Wellenhof R, Schoellnast R, et al.
(2005) Cellular phones in Clinical Teledermatology. Arch Dermatol 141:
1319–1320.
2. Massone C, Lozzi GP, Wurm E, Hofmann-Wellenhof R, Schoellnast R, et al.
(2006) Personal digital assistants in teledermatology. Br J Dermatol 154:
801–802.
3. Braun RP, Vecchietti JL, Thomas L, Prins C, French LE, et al. (2005)
Telemedical wound care using a new generation of mobile telephones:
a feasibility study. Arch Dermatol 141: 254–258.
4. Eedy DJ, Wootton R (2001) Teledermatology: a review. Br J Dermatol 144:
696–707.
5. Burg G, Hasse U, Cipolat C, Kropf R, Djamei V, et al. (2005) Teledermatology:
just cool or a real tool? Dermatology 210: 169–173.
6. Lens MB, Dawes M (2004) Global perspectives of contemporary epidemiological
trends of cutaneous malignant melanoma. Br J Dermatol 150: 179–185.
7. Diepgen TL, Mahler V (2002) The epidemiology of skin cancer. Br J Dermatol
146(Suppl 61), 1–6.
8. Schaffer JV, Rigel DS, Kopf AW, Bolognia JL (2004) Cutaneous melanoma–
past, present, and future. J Am Acad Dermatol 51(1 Suppl), S65–69.
9. Balch CM, Soong SJ, Atkins MB, Buzaid AC, Cascinelli N, et al. (2004) An
evidence-based staging system for cutaneous melanoma. CA Cancer J Clin 54:
131–149.
10. Tsao H, Atkins MB, Sober AJ (2004) Management of cutaneous melanoma.
N Engl J Med 351: 998–1012.
11. Massone C, Di Stefani A, Soyer HP (2005) Dermoscopy for skin cancer
detection. Curr Opinion Oncol 17: 147–153.
12. Grin CM, Kopf AW, Welkovich B, Bart RS, Levenstein MJ (1990) Accuracy in
the clinical diagnosis of malignant melanoma. Arch Dermatol 126: 763–766.
13. Wolf IH, Smolle J, Soyer HP, Kerl H (1998) Sensitivity in the clinical diagnosis
of malignant melanoma. Melanoma Res 8: 425–429.
14. Kittler H, Pehamberger H, Wolff K, Binder M (2002) Diagnostic accuracy of
dermoscopy. Lancet Oncol 3: 159–165.
15. Argenziano G, Soyer HP (2001) Dermoscopy of pigmented skin lesions–
a valuable tool for early diagnosis of melanoma. Lancet Oncol 2: 443–449.
16. Soyer HP, Hofmann-Wellenhof R, Massone C, Gabler G, Dong H, et al. (2005)
telederm.org: Freely Available Online Consultations in Dermatology. PLoS
Medicine 2: e87.
17. Provost N, Kopf AW, Rabinovitz HS, Stolz W, DeDavid M, et al. (1998)
Comparison of conventional photographs and telephonically transmitted
compressed digitized images of melanomas and dysplastic nevi. Dermatology
196: 299–304.
18. Piccolo D, Smolle J, Wolf IH, Peris K, Hofmann-Wellenhof R, et al. (1999)
Face-to-face diagnosis vs telediagnosis of pigmented skin tumors: a teledermo-
scopic study. Arch Dermatol 135: 1467–1471.
19. Piccolo D, Smolle J, Argenziano G, Wolf IH, Braun R, et al. (2000)
Teledermoscopy–results of a multicentre study on 43 pigmented skin lesions.
J Telemed Telecare 6: 132–137.
20. Braun RP, Meier M, Pelloni F, Ramelet AA, Schilling M, et al. (2000)
Teledermatoscopy in Switzerland: a preliminary evaluation. J Am Acad
Dermatol 42: 770–775.
21. Moreno-Ramirez D, Ferrandiz L, Bernal AP, Duran RC, Martin JJ, et al. (2005)
Teledermatology as a filtering system in pigmented lesion clinics. J Telemed
Telecare 11: 298–303.
22. Carli P, de Giorgi V, Chiarugi A, Nardini P, Weinstock MA, et al. (2004)
Addition of dermoscopy to conventional naked-eye examination in melanoma
screening: a randomized study. J Am Acad Dermatol 50: 683–689.
23. Grob JJ, Bonerandi JJ (1998) The ‘ugly duckling’ sign: identification of the
common characteristics of nevi in an individual as a basis for melanoma
screening. Arch Dermatol 134: 103–104.
24. Meystre S (2005) The current state of telemonitoring: a comment on the
literature. Telemed J E Health 11: 63–69.
25. Shapiro M, James WD, Kessler R, Lazorik FC, Katz KA, et al. (2004)
Comparison of skin biopsy triage decisions in 49 patients with pigmented lesions
and skin neoplasms: store-and-forward teledermatology vs face-to-face derma-
tology. Arch Dermatol 140: 525–528.
26. European Commission Information Society and Media (2006) ICT for Health
and i2010 - Transforming the European healthcare landscape – Towards
a strategy for ICT and Health. June 06: 9.
Melanoma Screening
PLoS ONE | www.plosone.org 4 May 2007 | Issue 5 | e483